Panic Disorder
📧 Sign up to get email alerts when something new happens for Panic Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: Neural Functioning Underlying Anxiety and Its Treatment (The INSULA Study) [NA]
A completed clinical trial update (INSULA study) from UC San Diego examining neural functioning underlying anxiety and its treatment, focusi…
-
FDA approval · 2012-12-21FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for sertraline hydrochloride by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2012-12-18FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for Paxil (paroxetine hydrochloride) submitted by Apotex Corp.
-
FDA approval · 2012-12-18FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2012-12-11FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride from Vertical Pharmaceuticals, LLC, expanding the drug’s approved …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-11-29FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for alprazolam from Sandoz Inc under an Abbreviated New Drug Application, resulting in an approved a…
-
FDA approval · 2012-11-29FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Alprazolam by Sandoz Inc, a generic benzodiazepine used to treat anxiety disorders such as g…
-
FDA approval · 2012-10-25FDA Approved: CLONAZEPAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for clonazepam from Aurobindo Pharma Limited under an ANDA, confirming continued availability of thi…
-
CLINICAL_TRIALS trial_result · 2012-10-22Clinical Trial Update: Risperidone vs. Paroxetine for Panic Attacks [Phase 2]
Phase 2 trial comparing risperidone to paroxetine for panic attacks was terminated. The study enrolled patients with panic disorder and majo…
-
CLINICAL_TRIALS trial_result · 2012-10-01Clinical Trial Update: Drug Use Investigation of Jzoloft.
A completed clinical trial for Jzoloft investigated its use in panic disorder and depression, with results posted in 2012.
-
FDA approval · 2012-10-01FDA Approved: FLUOXETINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original (ANDA) application for fluoxetine from Heritage Pharmaceuticals (d/b/a Avet), confirming a generic formulation of …
-
FDA approval · 2012-09-27FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for fluoxetine from Aurobindo Pharma Limited, allowing the generic product to be marketed under the …
-
CLINICAL_TRIALS trial_result · 2012-09-21Clinical Trial Update: Special Investigation Of J Zoloft For Panic Disorder Patients
Clinical trial update for sertraline (J Zoloft) in Panic Disorder; the study is completed with results posted in 2012.
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approval of a supplemental application for venlafaxine from BluePoint Laboratories (ANDA).
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for venlafaxine hydrochloride from Aurobindo Pharma Limited, resulting in approval of a generic venl…
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride submitted by Teva Pharmaceuticals USA, Inc., resulting in changes to t…
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for venlafaxine hydrochloride from Aurobindo Pharma Limited.
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride from Zydus Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Special Investigation Of Long Term Use Of Sertraline.
A completed clinical trial update investigating long-term sertraline use, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Treatment of Panic Disorder Via Internet With a Wireless Temperature Biofeedback Ring [NA]
The trial evaluated internet-based treatment for panic disorder using a wireless temperature biofeedback ring. However, the study was termin…
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Treatment of Panic Disorder Via Internet With a Wireless Temperature Biofeedback Ring [NA]
Clinical trial update indicating the termination of a study evaluating internet-based treatment for panic disorder using a wireless temperat…
-
FDA approval · 2012-07-31FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluoxetine hydrochloride from PAI Holdings (PAI Pharma), confirming approval of a generic fluoxe…
-
FDA approval · 2012-07-31FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for venlafaxine by Alembic Pharmaceuticals Inc. to support a generic version of the antidepressant. …
-
FDA approval · 2012-07-31FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for a generic paroxetine hydrochloride product submitted by NorthStar Rx LLC.